Richard Doll Seminar On the predictive nature of Bayesian inference
Professor Chris Holmes
4 June 2024
Richard Doll Seminar Opium as a carcinogen: new insights from the Golestan Chort Study
Professor Reza Malekzedah
28 May 2024
Richard Doll Seminar The Neonatology Canon project: examining the research endeavour through comprehensive aggregation of randomized trials
Associate Professor John A. Zupancic
21 May 2024
Richard Doll Seminar Broader, narrower, more or less - lessons about antibiotics and infection from routinely collected data
Professor David Eyre
7 May 2024
Richard Doll Seminar The UK Biobank story: transforming future health
Professor Naomi Allen
30 April 2024
Richard Doll Seminar The ongoing effort to generate the evidence needed to inform decisions about health and healthcare - A U.S. perspective
Dr Robert Califf
20 February 2024
Richard Doll Seminar Disease of poverty rhythms with poor data and recommendations
Professor Philippe Guerin
13 February 2024
Richard Doll Seminar Quantifying Regression Dilution and Residual Confounding in Epidemiology
Professor Sir Richard Peto
17 October 2023
Richard Doll Seminar Counting the dead: Using wearables to transform epidemiological research
Professor Aiden Doherty
21 November 2023
Richard Doll Seminar The health consequences of racism and xenophobia
Professor Delan Devakumar
9 May 2023
Richard Doll Seminar
Effective System Working: what are the health benefits of working with wider system partners?
Ansaf Azhar
Harvard-Oxford Seminar Brain health begins with brain care: preventing dementia, depression and stroke on the global level
Professor Jonathan Rosand
7 March 2023
Richard Doll Seminar Counting the dead: nationwide studies of premature mortality
Professor Prabhat Jha
2 May 2023
Richard Doll Seminar Triangulation of evidence in aetiological epidemiology: principles, prospects, limitations
Professor George Davey Smith
21 February 2023
Richard Doll Seminar Tobacco: the past 75 years and the next 75 years
Professor Richard Peto
28 February 2023
Richard Doll Seminar
Lord Gus O'Donnell
8 November 2022
Richard Doll Seminar
Tackling ethnic inequalities in experience and outcome of severe mental illness
Professor Kamaldeep Bhui
18 October 2022
Richard Doll Seminar Clinical trials in emerging infectious diseases
Sir Peter Horby
1 November 2022
Richard Doll Seminar Bayesian methods for clinical trials: useful or just a distraction?
Professor Peter Juni
22 November 2021
Richard Doll Seminar Polygenic Risk Scores and Our Future Health
Professor David Hunter
11 October 2022
Richard Doll Seminar Public Sector research and Industry: or There and Back Again
Mr Mahesh Pancholi
1 March 2022
Richard Doll Seminar Large-scale randomised evidence: trials and meta-analyses
Professor Sir Richard Peto
4 February 2022
Richard Doll Seminar Building local community focused research capacity in East Africa and elsewhere: 12 years of MicroResearch experience
Dr Noni MacDonald
8 June 2021
Richard Doll Seminar: The IRIS Initiative investigates changes in invasive disease in 26 countries during the COVID-19 pandemic
Professor Angela Brueggemann
15 June 2021
Richard Doll Seminar: INTERCOVID: A prospective study of the effects of COVID-19 in pregnancy
Professor Jose Villar
1 June 2021
Harvard-Oxford Program in Epidemiology mini-symposium
21 May 2021
Richard Doll Seminar:
The impact of COVID-19 outbreak on mortality in Wuhan, the epicentre of pandemic in China​
Professor Zhengming Chen
11 May 2021
Who's health is it anyway? Repositioning health as our most untapped opportunity for prosperity and happiness
Dr Jonathan Pearson-Stuttard
9 March 2021
The road to cervical cancer elimination: what will it involve and how long will it take?
Professor Karen Canfell
9 March 2021
Evaluating biomarkers and therapeutic targets for cardiovascular disease through applications of human genetics
Professor Michael Holmes
23 February 2021
OpenSAFELY.org: how and why we built a new, highly secure, open source analytics platform for 55 million patients' full linked health records during COVID-19
Dr Ben Goldacre
2 March 2021
Revolutionizing Healthcare: Turning the practice of medicine into a quantitative science
16 February 2021
Professor Mihaela van der Schaar
The International 100K+ Cohorts Consortium: Integrating large-scale cohorts to address global scientific challenges
Dr Geoffrey Ginsburg
9 February 2021
US Convalescent Plasma Program:
Insights and observations
Dr Scott WrightÂ
19 January 2021
Dr Scott Wright (Mayo Clinic) presents a Richard Doll Seminar on the US convalescent plasma program.
The journey from variants in the sequence of the genome and clinical phenotypes
Dr Kari Stefansson
26 January 2021
Kari Stefansson (deCODE) presents a Richard Doll Seminar on variants in the sequence of the genome and clinical phenotypes.
An Oxford Conversation: the impact of fake news on our lives
30 January 2020
Sir Simon Stevens, Chief Executive of NHS England, Damian Collins MP, and Sarah Montague, presenter at BBC Radio 4, discuss the impact of fake news on our lives.
Hinchliffe Report 60th Anniversary
11 November 2019
Pharmaceutical policies in the long run: reflections on the 60th anniversary of the Hinchliffe Report